Ana San-Félix

8PUBLICATIONS
25CO-AUTHORS
Biologically active moleculesOrganic chemical synthesisGene and molecular therapyNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 01, 2025
A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial Virus.

Olaia Martí-Marí, Marta Moreno-Simoni, Ana Isabel Avilés-Alía

|Sep 02, 2024
Skeletal Transformations Observed in the Reaction of a Tricyclic Thymine Nucleoside with Dicarbonyl Compounds.

María-Cruz Bonache, Elisa G -Doyagüez, Raúl Benito-Arenas

|Jul 20, 2023
C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein.

Marta Gargantilla, Clara Francés, Anmol Adhav

|Feb 25, 2023
Insertion of an Amphipathic Linker in a Tetrapodal Tryptophan Derivative Leads to a Novel and Highly Potent Entry Inhibitor of Enterovirus A71 Clinical Isolates.

Olaia Martí-Marí, Rana Abdelnabi, Dominique Schols

|Jul 07, 2021
Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors†.

Olaia Martí-Marí, Belén Martínez-Gualda, Sofía de la Puente-Secades

|Dec 07, 2019
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors.

Belén Martínez-Gualda, Liang Sun, Olaia Martí-Marí

Pageof 2

Frequent Collaborators

5 joint publications

Federico Gago

4 joint publications

María-José Camarasa

3 joint publications

María-Jesús Pérez-Pérez

2 joint publications

Alberto Marina